Cargando…

Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways

Nonalcoholic fatty liver disease (NAFLD), manifested as the aberrant accumulation of lipids in hepatocytes and inflammation, has become an important cause of advanced liver diseases and hepatic malignancies worldwide. However, no effective therapy has been approved yet. Aurantio-obtusin (AO) is a ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Fei, Ding, Mingning, Gu, Yiqing, Fan, Guifang, Liu, Chuanyang, Li, Yijie, Sun, Rong, Wu, Jianzhi, Li, Jianchao, Xue, Xiaoyong, Li, Hongjuan, Li, Xiaojiaoyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787202/ https://www.ncbi.nlm.nih.gov/pubmed/35087411 http://dx.doi.org/10.3389/fphar.2021.826628

Ejemplares similares

Cassiae Semen improves non-alcoholic fatty liver disease through autophagy-related pathway
por: Ding, Mingning, et al.
Publicado: (2023)

Metabolomics of Aurantio-Obtusin-Induced Hepatotoxicity in Rats for Discovery of Potential Biomarkers
por: Xu, Longlong, et al.
Publicado: (2019)

Mosquito larvicidal activity of Cassia tora seed extract and its key anthraquinones aurantio-obtusin and obtusin
por: Mbatchou, Valentine C., et al.
Publicado: (2017)

Urine Metabolomics Study on Potential Hepatoxic Biomarkers Identification in Rats Induced by Aurantio-Obtusin
por: Xu, Longlong, et al.
Publicado: (2020)

Transcriptome and HPLC Analysis Reveal the Regulatory Mechanisms of Aurantio-Obtusin in Space Environment-Induced Senna obtusifolia Lines
por: Mao, Renjun, et al.
Publicado: (2022)

Anti-Inflammatory Effects of Aurantio-Obtusin from Seed of Cassia obtusifolia L. through Modulation of the NF-κB Pathway
por: Hou, Jingyi, et al.
Publicado: (2018)

Effect Assessment of Aurantio-Obtusin on Novel Human Renal Glomerular Endothelial Cells Model Using a Microfluidic Chip
por: Qin, Wen, et al.
Publicado: (2022)

Neuroprotective Effect of Aurantio-Obtusin, a Putative Vasopressin V(1A) Receptor Antagonist, on Transient Forebrain Ischemia Mice Model
por: Paudel, Pradeep, et al.
Publicado: (2021)

Identification of Metabolites of Aurantio-Obtusin in Rats Using Ultra-High-Performance Liquid Chromatography-Q-Exactive Orbitrap Mass Spectrometry with Parallel Reaction Monitoring
por: Qin, Shi-han, et al.
Publicado: (2021)

Full-Length Transcriptome Survey and Expression Analysis of Cassia obtusifolia to Discover Putative Genes Related to Aurantio-Obtusin Biosynthesis, Seed Formation and Development, and Stress Response
por: Deng, Yin, et al.
Publicado: (2018)

Ferulic Acid Ameliorates Hepatic Inflammation and Fibrotic Liver Injury by Inhibiting PTP1B Activity and Subsequent Promoting AMPK Phosphorylation
por: Wu, Jianzhi, et al.
Publicado: (2021)

Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK
por: Yang, Ying, et al.
Publicado: (2021)

Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
por: Xue, Xiaoyong, et al.
Publicado: (2021)

Self-eating: friend or foe? The emerging role of autophagy in fibrotic diseases
por: Li, Yajing, et al.
Publicado: (2020)

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
por: Li, Xiaojiaoyang, et al.
Publicado: (2021)

Extracellular vesicles: catching the light of intercellular communication in fibrotic liver diseases
por: Li, Yijie, et al.
Publicado: (2022)

Omega-3 Fatty Acids Attenuate Renal Fibrosis via AMPK-Mediated Autophagy Flux Activation
por: Han, Suyeon, et al.
Publicado: (2023)

BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling
por: Sheng, Dandan, et al.
Publicado: (2019)

Corn peptides attenuate non-alcoholic fatty liver disease via PINK1/Parkin-mediated mitochondrial autophagy
por: Yao, Zhicui, et al.
Publicado: (2023)

Radix Polygoni Multiflori and Its Main Component Emodin Attenuate Non-Alcoholic Fatty Liver Disease in Zebrafish by Regulation of AMPK Signaling Pathway
por: Yu, Linyuan, et al.
Publicado: (2020)

Autophagy and Non-Alcoholic Fatty Liver Disease
por: Lavallard, Vanessa J., et al.
Publicado: (2014)

Therapeutic effects of isosteviol sodium on non-alcoholic fatty liver disease by regulating autophagy via Sirt1/AMPK pathway
por: Mei, Ying, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy
por: Jang, Hyun-Jun, et al.
Publicado: (2023)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis
por: Ma, Mengyao, et al.
Publicado: (2021)

The AMPK pathway in fatty liver disease
por: Fang, Chunqiu, et al.
Publicado: (2022)

Silibinin Restores NAD(+) Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
por: Salomone, Federico, et al.
Publicado: (2017)

A novel pulmonary fibrosis murine model with immune‐related liver injury
por: Jia, Kexin, et al.
Publicado: (2022)

Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)
por: Anggreini, Putri, et al.
Publicado: (2022)

Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway
por: Zhang, Ying, et al.
Publicado: (2020)

Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome
por: Tian, Ruifeng, et al.
Publicado: (2023)

Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
por: Wu, Jianzhi, et al.
Publicado: (2020)

Inhibition of Hepatic AMPK Pathway Contributes to Free Fatty Acids-Induced Fatty Liver Disease in Laying Hen
por: Huang, Cheng, et al.
Publicado: (2022)

Phosphorylation of eIF2α signaling pathway attenuates obesity-induced non-alcoholic fatty liver disease in an ER stress and autophagy-dependent manner
por: Li, Jie, et al.
Publicado: (2020)

Impaired Rab7 and dynamin2 block fat turnover by autophagy in alcoholic fatty livers
por: Li, Yuan, et al.
Publicado: (2017)

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice
por: Ideta, Takayasu, et al.
Publicado: (2015)

Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
por: Guo, Tingli, et al.
Publicado: (2023)

The phosphorylation of AMPKβ1 is critical for increasing autophagy and maintaining mitochondrial homeostasis in response to fatty acids
por: Desjardins, Eric M., et al.
Publicado: (2022)

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway
por: Li, Qian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vfuf4asp747f3dntda9todjpga